Search Within

GDMT, Surgery

  1. "Early Drug Development Service"
Formats
  1. Journal Article (11)
  2. Meeting Abstract (5)
Groups
  1. Department of Medicine (16)
  2. Early Drug Development Service (16)
  3. Gynecology Disease Management Team (16)
  4. Solid Tumor Oncology Division (16)
  5. Surgery (16)
  6. GDMT, Medicine (10)

More Groups

People
  1. David Hyman (13)
  2. Carol Aghajanian (9)
  3. Jennifer Mueller (6)
  4. Nadeem Abu-Rustum (6)
  5. Rachel Grisham (6)
  6. Vicky Makker (6)

More People

Years
  1. 2024 (2)
  2. 2022 (1)
  3. 2020 (2)
  4. 2019 (2)
  5. 2018 (3)
  6. 2016 (2)

More Years

Publications
  1. Gynecologic Oncology (5)
  2. Journal of Clinical Oncology (2)
  3. Breast Cancer Research and Treatment (1)
  4. Cancer Epidemiology Biomarkers and Prevention (1)
  5. Clinical Cancer Research (1)
  6. European Journal of Cancer (1)

More Publications

Publishers
  1. Elsevier Inc. (6)
  2. American Society of Clinical Oncology (3)
  3. American Association for Cancer Research (2)
  4. American Medical Association (1)
  5. Elsevier B.V. (1)
  6. Lippincott Williams & Wilkins (1)

More Publishers

Results (16)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical activity of tazemetostat, an EZH2 inhibitor, among patients with advanced endometrioid endometrial cancer and ovarian clear cell carcinoma with and without ARID1A mutations (NRG-GY014)
    Meeting Abstract

    Schram, A.; Eskander, R.; Sill, M.; Hagemann, A.; Waggoner, S.; Press, J.; Ghamande, S.; Zivanovic, O.; Bottsford-Miller, J.; Aghajanian, C.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: A phase 2 trial with biomarker analyses
    Journal Article

    Friedman, C. F.; Manning-Geist, B. L.; Zhou, Q.; Soumerai, T.; Holland, A.; Da Cruz Paula, A.; Green, H.; Ozsoy, M. A.; Iasonos, A.; Hollmann, T.; more...
    Nature Medicine (2024)

    Fulltext@MSK | Save
  • Dysfunctional CD8+T cells in the tumor microenvironment are associated with response to nivolumab in mismatch repair deficient (dMMR) or hypermutated ovarian (OVCA) or endometrial cancer (EC)
    Meeting Abstract

    Friedman, C. F.; Zhou, Q.; Iasonos, A.; Holland, A.; Ramirez, L.; Grisham, R. N.; Guo, R.; Lichtman, S. M.; Kyi, C.; Makker, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Community partnerships expand access to tumor molecular profiling
    Meeting Abstract

    Reynolds, T.; Jack, K.; Kemeny, M.; Bulone, L.; Gonsky, J.; Kampel, L. J.; Hyman, D.; Solit, D. B.; Conklin, C.; McMillan, S.; more...
    Cancer Epidemiology Biomarkers and Prevention (2020)

    Fulltext@MSK | Save
  • Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer
    Journal Article

    Stasenko, M.; Tunnage, I.; Ashley, C. W.; Rubinstein, M. M.; Latham, A. J.; Da Cruz Paula, A.; Mueller, J. J.; Leitao, M. M. Jr; Friedman, C. F.; Makker, V.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Understanding inherited risk in unselected newly diagnosed patients with endometrial cancer
    Journal Article

    Cadoo, K. A.; Mandelker, D. L.; Mukherjee, S.; Stewart, C.; DeLair, D.; Ravichandran, V.; Srinivasan, P.; Hurley, D.; Kemel, Y.; Arnold, A. G.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Use, safety, and efficacy of single-patient use of the US Food and Drug Administration Expanded Access Program
    Journal Article

    Feit, N. Z.; Goldman, D. A.; Smith, E.; Deighan, J.; Iasonos, A.; Zivanovic, O.; Hyman, D. M.
    JAMA Oncology (2019)

    Fulltext@MSK | Save
  • The clinical utility of prospective molecular characterization in advanced cervical and vulvovaginal cancer
    Meeting Abstract

    Friedman, C. F.; Donoghue, M.; Vivek, M.; Aghajanian, C.; Abu-Rustum, N.; Cadoo, K. A.; Grisham, R. N.; Hensley, M. L.; Konner, J. A.; Kyi, C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Utilization, safety, and efficacy of the FDA compassionate use program
    Meeting Abstract

    Feit, N.; Smith, E.; Cambria, R.; Anopa, J.; Deighan, J.; Pamer, E.; Wilson, R.; Greenfield, J.; Zivanovic, O.; Hyman, D.
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • Clinical utility of prospective molecular characterization in advanced endometrial cancer
    Journal Article

    Soumerai, T. E.; Donoghue, M. T. A.; Bandlamudi, C.; Srinivasan, P.; Chang, M. T.; Zamarin, D.; Cadoo, K. A.; Grisham, R. N.; O'Cearbhaill, R. E.; Tew, W. P.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save